GSK

News

Nuvalent buy delivers new cancer approval for GSK

GSK has its first approval from the $10.6bn takeover of Nuvalent, ROS1+ NSCLC therapy Jideytro, which becomes the company's first lung cancer product.

News

GSK abandons cough drug added in $2bn Bellus deal

Three years after buying Bellus Health and its chronic cough candidate camlipixant for around $2 billion, GSK is abandoning the programme.

News

UK experts call for meningitis shots for all 15-year-olds

All 15-year-olds in the UK should be offered the meningitis B vaccine following the fatal outbreaks earlier this year, says the JCVI.

News

GSK to file Jemperli for rectal cancer after phase 3 readout

GSK's pivotal AZUR-1 trial of Jemperli monotherapy to delay or eliminate surgery in pre-operative rectal cancer has delivered a positive result.

News

GSK ends dementia alliance with Alector after setbacks

GSK's alliance with Alector to develop two drug candidates for dementia has been terminated in the wake of disappointing clinical trial results.

News

With measles cases rising, UK launches vaccination drive

With measles cases rising, the UK has launched a campaign urging around a million families to book the new four-in-one MMRV vaccine.

Nuvalent buy delivers new cancer approval for GSK

GSK abandons cough drug added in $2bn Bellus deal

UK experts call for meningitis shots for all 15-year-olds

GSK to file Jemperli for rectal cancer after phase 3 readout

GSK ends dementia alliance with Alector after setbacks

With measles cases rising, UK launches vaccination drive

Dexcom is first to join FDA/CMS health tech pilot

Discover a new era of healthcare panel engagement: Grounded ...

GSK

Editor's Picks